Geneos Wealth Management’s RenaissanceRe RNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.9K Hold
50
﹤0.01% 1877
2025
Q4
$14.1K Sell
50
-200
-80% -$52.6K ﹤0.01% 1861
2025
Q3
$63.5K Sell
250
-317
-56% -$76.8K ﹤0.01% 1287
2025
Q2
$138K Sell
567
-655
-54% -$159K ﹤0.01% 1127
2025
Q1
$293K Buy
1,222
+837
+217% +$203K ﹤0.01% 1084
2024
Q4
$95.8K Hold
385
﹤0.01% 1085
2024
Q3
$105K Buy
385
+135
+54% +$32.6K ﹤0.01% 950
2024
Q2
$55.9K Sell
250
-6
-2% -$1.34K ﹤0.01% 1035
2024
Q1
$60.2K Buy
256
+6
+2% +$1.33K ﹤0.01% 1005
2023
Q4
$49K Hold
250
﹤0.01% 1067
2023
Q3
$49.5K Hold
250
﹤0.01% 1081
2023
Q2
$46.6K Hold
250
﹤0.01% 1102
2023
Q1
$50.1K Hold
250
﹤0.01% 1085
2022
Q4
$46.1K Hold
250
﹤0.01% 1085
2022
Q3
$35K Buy
250
+50
+25% +$6.94K ﹤0.01% 1150
2022
Q2
$31K Buy
+200
New +$30.3K ﹤0.01% 1484

Other funds holding RNR

Geneos Wealth Management's RNR Position: Q1 2026 in Review

Geneos Wealth Management held its RenaissanceRe (RNR) position steady in Q1 2026 at 50 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1877.

Geneos Wealth Management first reported a position in RNR in Q2 2022 and has held it in 16 quarters since. The position peaked at $293K in Q1 2025. 556 funds tracked by Wall St. Rank hold RNR as of Q1 2026.

  • Geneos Wealth Management held 50 shares of RenaissanceRe worth $14.9K as of Q1 2026.
  • Geneos Wealth Management left its RenaissanceRe share count unchanged in Q1 2026.
  • RenaissanceRe made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1877 holding.
  • Geneos Wealth Management first reported a position in RenaissanceRe in Q2 2022 and has held it in 16 quarters since.
  • Geneos Wealth Management's RenaissanceRe position peaked at $293K in Q1 2025.
  • 556 funds tracked by Wall St. Rank held RenaissanceRe as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.